Heron Therapeutics stock rockets 31% on high hopes for post-surgery pain treatment
June 21, 2018 at 12:48 PM EDT
Heron Therapeutics Inc. shares surged 33.6% Thursday, after the company announced positive developments for its treatments for postoperative pain that aim to reduce patient dependence on opioids. A competitor’s stock slumped.
